TESS Research Foundation is a 501(c)(3) tax exempt public charity that helps families affected by SLC13A5 Deficiency (also known as Citrate Transporter Disorder). Its mission is to help families affected by SLC13A5 Deficiency and create disease-modifying treatments. To diagnose, treat, and ultimately cure SLC13A5 Deficiency, the foundation is building a patient-centered network from the ground up, funding cutting-edge research, and connecting patients, doctors, and researchers. For more information, visit https://www.tessresearch.org.
Disclaimer: The information contained in this page is provided by the partnering patient organization for informational purposes only. The 40 Percent Inc. does not warrant its completeness or accuracy, and it should not be construed as an endorsement by The 40 Percent Inc. or relied upon as a basis for your support for the partnering patient organization. The information is subject to change without notice.